bioAffinity Technologies, Inc. Strategic Asset Allocation Index

Latest as of September 2022: 0.0%

bioAffinity Technologies, Inc. strategic asset allocation index. bioAffinity Technologies, Inc. (BIAF) has a Strategic Asset Allocation Index of 0.0% as of September 2022. Strategic assets (PP&E of $1.78K plus long-term investments of $-) total $1.78K, measured against net assets of $12.60 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See bioAffinity Technologies, Inc. (BIAF) balance sheet quality index to measure how much of total assets are equity-financed.

SAAI

0.0%

Strategic Assets / Net Assets

Strategic Assets

$1.78K

PP&E + LT Investments

PP&E

$1.78K

USD

Net Assets

$12.60 Million

USD

bioAffinity Technologies, Inc. Strategic Asset Allocation Index by Year (None–None)

bioAffinity Technologies, Inc. strategic asset allocation index by year from None to None. The table below presents the year-by-year Strategic Asset Allocation Index for bioAffinity Technologies, Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see bioAffinity Technologies, Inc. (BIAF) market capitalisation.

Year	SAAI	Strategic Assets (USD)	PP&E	LT Investments	Net Assets	Change (pp)

pp = percentage points